STOUT JAY S (Chief Technology Officer) sold 1.6% of their position (3.49K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $137.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 7/10/2026ACC: 0001764013-26-000081
Officer· Chief Technology Officer
Since Apr 2023
-3.49K
Net shares
Net seller
$137.9K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
3.49K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−1.91K
Price / share
$39.53
Trade value
$75.34K
% of position
0.9%
7/8/2026
211.69K→209.78K
Common Stock
Direct
Shares
−105.00
Price / share
$39.99
Trade value
$4.20K
% of position
0.1%
7/8/2026
209.78K→209.67K
Common Stock
Direct
Shares
−1.40K
Price / share
$39.53
Trade value
$55.30K
% of position
0.7%
7/8/2026
209.67K→208.28K
Common Stock
Direct
Shares
−77.00
Price / share
$39.99
Trade value
$3.08K
% of position
0.0%
7/8/2026
208.28K→208.20K
Total
Net shares
−3.49K
Net value
-$137.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | S · Sale | −1.91K | $39.53 | $75.34K | 0.9% | 211.69K | 209.78K |
| Common Stock Direct | 7/8/2026 | S · Sale | −105.00 | $39.99 | $4.20K | 0.1% | 209.78K | 209.67K |
| Common Stock Direct | 7/8/2026 | S · Sale | −1.40K | $39.53 | $55.30K | 0.7% | 209.67K | 208.28K |
| Common Stock Direct | 7/8/2026 | S · Sale | −77.00 | $39.99 | $3.08K | 0.0% | 208.28K | 208.20K |
| Total | −3.49K | -$137.92K | ||||||
Derivative Transactions0
No derivative transactions reported